Thursday, May 4, 2017

Oncogene - Table of Contents alert Volume 36 Issue 18

If you are unable to see the message below, click here to view.


Volume 36, Issue 18 (May 2017)

In this issue
Original Articles
Short Communication

Also new
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed



Neutrophil extracellular traps: protagonists of cancer progression?

L Erpenbeck and M P Schön

Oncogene 2017 36: 2483-2490; advance online publication, December 12, 2016; 10.1038/onc.2016.406

Abstract | Full Text

Original Articles


A CDK2 activity signature predicts outcome in CDK2-low cancers

S R McCurdy, M Pacal, M Ahmad and R Bremner

Oncogene 2017 36: 2491-2502; advance online publication, November 7, 2016; 10.1038/onc.2016.409

Abstract | Full Text

The molecular mechanisms underlying the ERα-36-mediated signaling in breast cancer OPEN

S Omarjee, J Jacquemetton, C Poulard, N Rochel, A Dejaegere, Y Chebaro, I Treilleux, E Marangoni, L Corbo and M Le Romancer

Oncogene 2017 36: 2503-2514; advance online publication, December 12, 2016; 10.1038/onc.2016.415

Abstract | Full Text

A redox state-dictated signalling pathway deciphers the malignant cell specificity of CD40-mediated apoptosis OPEN

C J Dunnill, K Ibraheem, A Mohamed, J Southgate and N T Georgopoulos

Oncogene 2017 36: 2515-2528; advance online publication, November 21, 2016; 10.1038/onc.2016.401

Abstract | Full Text

ROCK2/rasHa co-operation induces malignant conversion via p53 loss, elevated NF-κB and tenascin C-associated rigidity, but p21 inhibits ROCK2/NF-κB-mediated progression

S F Masre, N Rath, M F Olson and D A Greenhalgh

Oncogene 2017 36: 2529-2542; advance online publication, December 19, 2016; 10.1038/onc.2016.402

Abstract | Full Text

Co-targeting of EGF receptor and neuropilin-1 overcomes cetuximab resistance in pancreatic ductal adenocarcinoma with integrin β1-driven Src-Akt bypass signaling

Y-J Kim, K Jung, D-S Baek, S-S Hong and Y-S Kim

Oncogene 2017 36: 2543-2552; advance online publication, October 31, 2016; 10.1038/onc.2016.407

Abstract | Full Text

Defective replication stress response inhibits lymphomagenesis and impairs lymphocyte reconstitution

M V Puccetti, M A Fischer, M P Arrate, K L Boyd, R J Duszynski, R Bétous, D Cortez and C M Eischen

Oncogene 2017 36: 2553-2564; advance online publication, October 31, 2016; 10.1038/onc.2016.408

Abstract | Full Text

The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer OPEN

C Wilson, L Qiu, Y Hong, T Karnik, G Tadros, B Mau, T Ma, Y Mu, J New, R J Louie, S Gunewardena, A K Godwin, O W Tawfik, J Chien, K F Roby and A J Krieg

Oncogene 2017 36: 2565-2576; advance online publication, November 21, 2016; 10.1038/onc.2016.412

Abstract | Full Text

Downregulation of miR-218 contributes to epithelial–mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling OPEN

Z-M Shi, L Wang, H Shen, C-F Jiang, X Ge, D-M Li, Y-Y Wen, H-R Sun, M-H Pan, W Li, Y-Q Shu, L-Z Liu, S C Peiper, J He and B-H Jiang

Oncogene 2017 36: 2577-2588; advance online publication, February 13, 2017; 10.1038/onc.2016.414

Abstract | Full Text

Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemia

S Goyama, M Shrestha, J Schibler, L Rosenfeldt, W Miller, E O’Brien, B Mizukawa, T Kitamura, J S Palumbo and J C Mulloy

Oncogene 2017 36: 2589-2598; advance online publication, November 7, 2016; 10.1038/onc.2016.416

Abstract | Full Text

c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun

X Xie, T S Kaoud, R Edupuganti, T Zhang, T Kogawa, Y Zhao, G B Chauhan, D N Giannoukos, Y Qi, D Tripathy, J Wang, N S Gray, K N Dalby, C Bartholomeusz and N T Ueno

Oncogene 2017 36: 2599-2608; advance online publication, December 12, 2016; 10.1038/onc.2016.417

Abstract | Full Text

Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway

C Urbinati, E Grillo, P Chiodelli, C Tobia, F Caccuri, S Fiorentini, G David and M Rusnati

Oncogene 2017 36: 2609-2618; advance online publication, November 7, 2016; 10.1038/onc.2016.420

Abstract | Full Text

Short Communication


CIB1 contributes to oncogenic signalling by Ras via modulating the subcellular localisation of sphingosine kinase 1

W Zhu, B L Gliddon, K E Jarman, P A B Moretti, T Tin, L V Parise, J M Woodcock, J A Powell, A Ruszkiewicz, M R Pitman and S M Pitson

Oncogene 2017 36: 2619-2627; advance online publication, December 12, 2016; 10.1038/onc.2016.428

Abstract | Full Text



Context-dependent differences in miR-10b breast oncogenesis can be targeted for the prevention and arrest of lymph node metastasis

M V Yigit, S K Ghosh, M Kumar, V Petkova, A Kavishwar, A Moore and Z Medarova

Oncogene 2017 36: 2628; advance online publication, November 14, 2016; 10.1038/onc.2016.413

Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: